Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

PIramed Limited

PIramed was founded by Professor Michael Waterfield FRS (Ludwig Institute for Cancer Research, London), Professor Peter Parker (Cancer Research UK) and Professor Paul Workman (Institute of Cancer Research, London). To date, the Company has received £10m in equity and convertible loans from JPMorgan Partners and Merlin Biosciences.Principal intellectual property licences are to PI 3-kinase p110a (from the Ludwig Institute of Cancer Research) and to small molecule inhibitors of PI 3-kinase superfamily members (from the Institutes and Astellas Pharma). The Company became operational in August 2003 and is based in state-of-the-art laboratory premises in Slough, Berkshire, UK.


Contact Details:
957 Buckingham Avenue
Slough
Berkshire
SL1 4NL
United Kingdom
Tel:44 (0)1753 285800
Fax:44 (0)1753 568367
Email:General@piramed.com
WWW:

www.piramed.com/




Loading...

Recent Publications by PIramed Limited:

A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.
The PI3K (phosphoinositide 3-kinase) pathway regulates cell proliferation,...
7th October, 2008
Cancer Research Institute, University of California, San Francisco, CA Biochem J. 2008 Oct 1;415(1):97-110.
DOI Direct Link
Role of intracellular kinases in the regulation of equine eosinophil migration and actin polymerization.
Inappropriately activated eosinophils can contribute to disease...
19th March, 2008
Department of Veterinary Basic Sciences and Pathology and Infectious J Vet Pharmacol Ther. 2008 Feb;31(1):31-8.
DOI Direct Link
Distribution of CCR3 mRNA expression in horse tissues.
CCL11 (also known as eotaxin) is a very potent and selective mediator of...
3rd March, 2007
Department of Veterinary Basic Sciences, The Royal Veterinary College, Vet Immunol Immunopathol. 2006 Dec 15;114(3-4):238-46. Epub 2006 Sep 18.
DOI Direct Link
Design and synthesis of protein superfamily-targeted chemical libraries for lead identification and optimization.
This review chronicles original literature dating back to 1992 outlining...
21st October, 2005
Department of Chemistry, Tularik Inc., 1120 Veterans Boulevard, South San Curr Med Chem. 2005;12(11):1239-81.

BioNews Results for PIramed Limited:

Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
Pharma Live:  Sep 1 2009 1:34PM Matching: piramed
Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
PR Newswire via Yahoo!:  Sep 1 2009 12:51PM Matching: piramed

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 850 times since April 2007, the link to the organisation's website has been followed 169 times

Recent Search Terms used to find this page: PIRAMED LTD | PIramed Limited | PIramed | piramed 2009 | piramed slough | piramed | Piramed Intellectual Property | Piramed Limited | PIramed | piramed slough | .

Search for more companies in Slough

Search for more companies in Berkshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for PIramed Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.